Global private equity and venture capital news and research

Archer, Ironbridge eye sale of iNova Pharmaceuticals

15 Sep 2011

Australian buy-out firms Ironbridge and Archer Capital are looking to sell their stake in iNova Pharmaceuticals for a value of between A$700m ($717.5m) and A$850m ($871m).

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016